Guidance for NHS providers and commissioners on the application of merger control rules to pathology service reconfigurations.
This document outlines how rules on mergers can affect changes to pathology services in the NHS.
It also details the roles of Monitor and the Office of Fair Trading in a merger review.
For further information about the content of this note, or any related issue, please contact email@example.com.
Questions for the OFT in relation to mergers should be addressed to firstname.lastname@example.org.